Kelly Van Looveren is Senior CMC Writer at Ardena Ghent. She supports pharmaceutical development programs through regulatory advice, scientific writing, and the preparation of CMC documentation for a broad range of development projects.
After joining Ardena as a CMC Writer, Kelly progressed to the role of Senior CMC Writer, building extensive experience across regulatory documentation and scientific reporting activities. She has worked on projects for major pharmaceutical companies and combines her expertise in CMC documentation with a strong background in biotechnology and large molecule development. At Ardena, she works closely with clients and multidisciplinary teams to support regulatory compliance and successful development outcomes.
Kelly graduated in Biochemistry and Biotechnology and obtained her PhD in Biomedical Biotechnology before joining Ardena.
